Scarica l'app Stockscreener
279.30
0.31%
0.85
Dopo l'orario di chiusura:
279.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference - StreetInsider
Global Lab Services Leader Labcorp to Present at Morgan Stanley's 23rd Annual Healthcare Conference - Stock Titan
What earnings revisions data tells us about Labcorp Holdings Inc.2025 Short Interest & Comprehensive Market Scan Insights - Newser
Do Wall Street Analysts Like Labcorp Holdings Stock? - inkl
What machine learning models say about Labcorp Holdings Inc.2025 Earnings Surprises & Technical Buy Zone Confirmations - Newser
Tools to assess Labcorp Holdings Inc.’s risk profileTrade Volume Report & Low Risk Growth Stock Ideas - Newser
Volatility clustering patterns for Labcorp Holdings Inc.2025 Price Targets & AI Forecast Swing Trade Picks - Newser
Using RSI to spot recovery in Labcorp Holdings Inc.July 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
How to build a dashboard for Labcorp Holdings Inc. stockTrade Exit Summary & High Accuracy Trade Alerts - Newser
Is it the Right Time to Hold Labcorp Stock in Your Portfolio? - sharewise.com
Analysts Bullish on Healthcare Stocks: Labcorp Holdings and Abivax SA Sponsored ADR - AInvest
Ex-Dividend Reminder: Labcorp Holdings, Cathay General Bancorp and First Bancorp - Nasdaq
How to read the order book for Labcorp Holdings Inc.Market Movement Recap & Daily Chart Pattern Signal Reports - Newser
Labcorp targets 2025 EPS growth of up to 10% with expanding margins - MSN
What high frequency data says about Labcorp Holdings Inc.July 2025 Opening Moves & Intraday High Probability Alerts - Newser
Is Labcorp Holdings Inc. showing signs of accumulation2025 Fundamental Recap & Daily Stock Momentum Reports - Newser
Is Labcorp Holdings Inc. trending in predictive chart models2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Company Statement: LabCorp extends tender offer for all outstanding shares of Orchid Cellmark Inc. - MLex
Full technical analysis of Labcorp Holdings Inc. stockJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Sector Leaders Rotate Capital Into Labcorp Holdings Inc.Watch List & AI Enhanced Trading Signals - kangso.co.kr
Applying Wyckoff theory to Labcorp Holdings Inc. stockMarket Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Baird Adjusts Price Target on Labcorp Holdings to $311 From $302, Maintains Outperform Rating - MarketScreener
Is Labcorp Holdings Inc. stock entering bullish territoryWall Street Watch & Reliable Intraday Trade Alerts - Newser
Labcorp Holdings Inc. stock trend outlook and recovery pathJuly 2025 Breakouts & Daily Volume Surge Signals - Newser
Be Sure To Check Out Labcorp Holdings Inc. (NYSE:LH) Before It Goes Ex-Dividend - simplywall.st
Should You Buy Labcorp Holdings Inc. (NYSE:LH) For Its Upcoming Dividend? - 富途牛牛
Analyzing recovery setups for Labcorp Holdings Inc. investors2025 Technical Overview & Safe Capital Growth Tips - Newser
What analysts say about Labcorp Holdings Inc. stockJuly 2025 Short Interest & Safe Capital Growth Tips - theviewers.co.kr
Published on: 2025-08-24 09:02:15 - theviewers.co.kr
Does Labcorp Holdings Inc. qualify in momentum factor screeningBear Alert & Daily Stock Trend Watchlist - Newser
Will Labcorp Holdings Inc. outperform small cap indexesProfit Target & Capital Efficient Trade Techniques - sundaytimes.kr
Labcorp Holdings Inc. shares rise 1.03% after-hours following a favorable patent lawsuit ruling. - AInvest
FDA-Cleared Blood Test for Alzheimer’s Might Change the Case for Investing in Labcorp (LH) - simplywall.st
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up - MSN
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock - Yahoo Finance
Trading Bots Trigger Alerts on Labcorp Holdings Inc. ActivityJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - Newser
Can Labcorp Holdings Inc. Escape Recent Bear ChannelCEO Change & Consistent Return Investment Signals - kangso.co.kr
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term - sharewise.com
Labcorp launches FDA-cleared blood test for Alzheimer's disease - MSN
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Wins ERISA Bench Trial, NextEra to Face Class Action - planadviser
Labcorp Holdings' Lumipulse pTau-217/Beta Amyloid 42 Ratio Launch Enhances Alzheimer's Diagnostics Capabilities, Supporting Revenue Growth - AInvest
Labcorp Holdings (LH) Launches FDA-Cleared Alzheimer's Diagnostic Blood Test Nationwide - Yahoo Finance
Federal Circuit overturns jury win for Labcorp in dispute with Qiagen - BioWorld MedTech
Price action breakdown for Labcorp Holdings Inc.July 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - simplywall.st
Published on: 2025-08-19 00:48:14 - beatles.ru
LabCorp Prevails in ERISA Trial, While Case Against NextEra Allowed to Proceed - plansponsor
Labcorp launches first FDA-cleared blood test for Alzheimer's disease - MarketScreener
Labcorp launches first FDA-cleared blood test for Alzheimer’s disease By Investing.com - Investing.com South Africa
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease - MarketScreener
Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis - Nasdaq
Labcorp Launches First FDA-Cleared Blood Test For Alzheimer's Disease - Barchart.com
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Real time scanner hits for Labcorp Holdings Inc. explainedJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
What’s next for Labcorp Holdings Inc. stock priceShare Buyback & AI Powered Market Entry Strategies - Newser
1.61%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):